Mani Mohindru
CIK 1664708 · Chief Executive Officer · last filed 2026-04-02
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$0
Companies
4
Total Filings
26
Lifetime Open-Market Net
-$2.05M
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| CRDF | Chief Executive Officer | — | $1.54 | — | $0 | 7 | 2026-04-02 |
| CTMX | Director | — | $3.01 | — | $0 | 6 | 2025-06-13 |
| Tvardi Therapeutics, Inc. (CARA) Delisted | CFO & Chief Strategy Officer | 17,441 | $15.96 | $278.4K | -$2.05M | 10 | 2019-12-04 |
| CRIS | Chief Strategy Officer | — | $0.42 | — | $0 | 3 | 2017-02-16 |
Recent Filings · Page 2 of 3
26 filingsForm 4 transactions across all companies, newest first.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2021-06-17 | CTMX | Grant (A) | — | $0 | EDGAR |
| 2021-06-14 | CRDF | Grant (A) | — | $0 | EDGAR |
| 2020-12-18 | CTMX | Grant (A) | — | $0 | EDGAR |
| 2019-12-04 | Tvardi Therapeutics, Inc. (CARA) Delisted | Mixed | +3,578 | -$81.1K | EDGAR |
| 2019-07-17 | Tvardi Therapeutics, Inc. (CARA) Delisted | Mixed | — | -$409.5K | EDGAR |
| 2019-05-30 | Tvardi Therapeutics, Inc. (CARA) Delisted | Mixed | +5,837 | -$53.4K | EDGAR |
| 2019-03-15 | Tvardi Therapeutics, Inc. (CARA) Delisted | Mixed | — | -$81.2K | EDGAR |
| 2019-03-08 | Tvardi Therapeutics, Inc. (CARA) Delisted | Grant (A) | — | $0 | EDGAR |
| 2019-01-02 | Tvardi Therapeutics, Inc. (CARA) Delisted | Sell (S) | −4,500 | -$56.5K | EDGAR |
| 2018-12-31 | Tvardi Therapeutics, Inc. (CARA) Delisted | Grant (A) | +12,526 | $0 | EDGAR |
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.